Exane BNP Paribas analyst James Picariello downgrades Goodyear Tire & Rubber (NASDAQ:GT) from Neutral to Underperform.
Reported Late Tuesday, Eleven Experts From Leading Medical Institutions And Eight Experts From Eisai Publish Full Results Of Lecanemab Phase 3 Confirmatory Clarity AD Study For Early Alzheimer’s Disease In The New England Journal Of Medicine
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (NASDAQ:BIIB, Corporate headquarters: , Cambridge, Massachusetts, CEO: , Christopher A. Viehbacher,
